Anzu Special Acquisition Corp I (NASDAQ:ANZU – Get Free Report) and Milestone Scientific (NYSE:MLSS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, analyst recommendations and institutional ownership.
Insider & Institutional Ownership
27.3% of Anzu Special Acquisition Corp I shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 0.7% of Anzu Special Acquisition Corp I shares are held by insiders. Comparatively, 25.2% of Milestone Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Valuation and Earnings
This table compares Anzu Special Acquisition Corp I and Milestone Scientific’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Anzu Special Acquisition Corp I||N/A||N/A||$19.23 million||N/A||N/A|
|Milestone Scientific||$9.96 million||5.85||-$8.71 million||($0.10)||-8.17|
Volatility and Risk
Anzu Special Acquisition Corp I has a beta of 0.03, indicating that its stock price is 97% less volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500.
This is a summary of recent ratings and recommmendations for Anzu Special Acquisition Corp I and Milestone Scientific, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Anzu Special Acquisition Corp I||0||0||0||0||N/A|
This table compares Anzu Special Acquisition Corp I and Milestone Scientific’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Anzu Special Acquisition Corp I||N/A||-17.33%||1.37%|
Anzu Special Acquisition Corp I beats Milestone Scientific on 5 of the 8 factors compared between the two stocks.
About Anzu Special Acquisition Corp I
Anzu Special Acquisition Corp I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of industrial applications. Anzu Special Acquisition Corp I was incorporated in 2020 and is based in Tampa, Florida. Anzu Special Acquisition Corp I operates as a subsidiary of Anzu SPAC GP I LLC.
About Milestone Scientific
Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
Receive News & Ratings for Anzu Special Acquisition Corp I Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anzu Special Acquisition Corp I and related companies with MarketBeat.com's FREE daily email newsletter.